下列何者不通過肺門胸管

(B) 1. �U�C��@�تͯe�f��ݩ��ʪͯf�H A. Asthma B. Sarcoidosis C. Bronchiectasis D. Cystic fibrosis E. Bronchiolitis (B) 2. �U�C��دݳ��f�_�Amagnetic resonance imaging (MRI) �L�k��N�q��_�h��v (CT)�H A. �ݾ� (Chest wall)�C B. �a�J�� (Mediastinum)�C C. �ͦ�� (Pulmonary vessels)�C D. �ͳn��´ (Soft tissue densities)�C E. �ͪ� (Hilar regions)�C (D) 3. ��¾�~�ʤ��ޭ��ݯg (Occupational asthma) ��o�f��A�U�C��̳̱`��H A. �Ϯg�ʧ@�� (Reflex)�C B. �o�� (Inflammation)�C C. �Ī��@�� (Pharmacologic reaction)�C D. �L�Ӥ�� (Allergic reaction)�C E. �H�W�ҫD�C (A) 4. ��X�� (exudative) �ؽ��n��`�X�{�b�U�C��دe�f�H A. Asbestos exposure B. Cirrhosis C. Myxedema D. Nephrotic syndrome E. Superior vena cava obstruction (E) 5. �C�ʪ��ʪͯf�w�̱��Ͳ��Ӥ�N��A�U�C��̥��T�H A. �l�J��X�i��A�ΤO�Ĥ@��R��q (FEV1) �C��w��Ȥ�30%�C B. �R��A��PaO2�p��55-60�@�̨E�W�C C. �Y��o�ʪͰʯ߰��C D. ��`��Y��C E. �H�W�ҬO�C (E) 6. �U�C�U��y��ͮ�몺�M�I�]�l��A��̬��D�H A. �έD�C B. ��קɡC C. �U��R�߽F�C D. ��C E. ��ҡC (C) 7. �U�C��ʪͯf��A��̸��`�X�{�ת޸~ (granuloma) �f�ܡH A. Idiopathic pulmonary fibrosis B. Pulmonary alveolar proteinosis C. Hypersensitivity pneumonitis D. Asbestos E. Eosinophilic pneumonias (B) 8. �U�C��ֽF (mesothelioma) ��ԭz�A��̤��T�H A. �i�o�ͦb�ؽ� (pleura) �θ�� (peritonium)�C B. �P��Ҧ��C C. �P��S�b�۴��Ҧ��C D. �h�Ưf�H�|�ֵo�ؽ��n��C E. ��e��P�͸�� (adenocarcinoma) �Ϥ��C (D) 9. �U�C��Ī��P��P (theophylline) �X�ήɡA�|��w��P��ư��H 1. Macrolide antibiotics 2. Allopurinol 3. Phenytoin 4. Isoniazid 5. Furosemide A. 1,3 B. 1,2 C. 3,4 D. 1,2,4 E. 1,3,4,5 (D) 10. ��j�y�媺�B�m�A�U�C�U��̥��T�H 1. ��A�q��R��A�H�קK�f�H�]��ʦӻ��o�A�ץX��C 2. �N�X�峡��m��U��A�H�קK�A�X��C 3. ��A�q��y��A�H�קK�f�H�]�Y��y�¦ӻ��o�X��C 4. �ѵ��A�H�ﵽ�ʮ�{�H�C 5. ��קɥ𮧡A��I�A�H�P�i�f�H�Ʒ�A�קK�l�J�ʪͪ��C A. 1,2,3 B. 2,3,4 C. 1,2,4 D. 1,3,4 E. 1,2,3,4,5 (D) 11. �ϥί��P (theophylline) �v��ޭ�� (bronchial asthma) �㦳�U�C�u�I�A��̰��~�H A. ��X�i�@�� (bronchodilation)�C B. �ܵo��@�� (anti-inflammation)�C C. �ﵽ��֤�׶��\�� (mucociliary clearance)�C D. ��W�ϥήɡA��A��P��g��E�� (�]-agonist) ��ġC E. �[�j��J��Y�A�i�W�i�I�l�\��C (A) 12. �Ϥ@�O�ͥ\��ˬd��I��y�q�Юe�n��u (flow-volume curve)�A��@��u�O�N��ʯe�f�H A. 1 B. 2 C. 3 D. 4 E. 2,3 (B) 13. �@��20��Ӱ��d��k�ʡA��M�o�ͦ۵o�ʮ�ݡA��ݳ�X��p�ϤG�ҥܡC�հݸӵ��تv��H A. �q��U�ض��J�ݺޤޥX�Ů�C B. �q��W�ض��H�Ӱw��X�Ů�C C. �u��R�i�A�@�P��A�ӯݳ�X��C D. �ߧY�l�J100%��A�P�i�Ů�l��C E. �ߧY�`�g��s��A�s�X�ؽ��C (E) 14. ��@�k�ʯf�H�A62��A�q�Y��Ǥ��Ӧ��|�A�D�D�I�l�x��A�a�Ӫ��i�O�ؽ��n�G�ӭM�Ǭ��A�ݳ�X��p�ϤT�A�аݤU�C��بB�J��u��H A. ��J�ݺޤެy�A��g��C B. ��J pig tail �Ӻޤެy�C C. �ΰw��A�C�Ѥ��W�L1000�@�ɡC D. ��W��i�ˬd�A�ݬݦ��L�~�F�C E. ��ˬd�A�ݤ��ެO�_��C (A) 15. �@��45��k�ʦ]�y�µo�N�ӶE�A�ݳ�X��p�ϥ|�A�аݤU�C��@�B�J�̬��A��H A. ��𤧧ܻĩʬV��C B. ��𤧲ӭM��ˬd�C C. �A�Ӥ@�i�k��ݳ�X��C D. ��cephalosporin�f�A�C E. ��macrolide�f�A�C (D) 16. �U�C��D��֤��K�� (nontuberculous Mycobacterium) �P�V��ԭz�A��̥��T�H A. ��r�� (virulence) �񵲮ֱ�ߧ�j�C B. �u�|�o�ͩ�R��f�H�C C. �ثe�̦��Ī��Ĥ��M�O isoniazid�C D. ��i�X��ߤ��@�w��ܦ��ͤ��P�V�C E. �ҿקֳt�ͪ��̬O��i2-3�g��X�̡C (B) 17. �U�C��ݳ�ť�E��I�l��ԭz�A��̿��~�H A. ��`�H�l��ɩI�l��I��ɧ�j�C B. �j��ʪͪ��f�H�I��ɩI�l��ܪ��O�]�f�H�I�l��A��ܡC C. �U�͸��ާ��ɡA�I�l��|��C D. �ؽ�� (friction rub) �`�b�l��M�I��ҥiť��C E. �嫬��Ͷ��ֺ��ƥiť��o��(crackles)�C (C) 18. �U�C��ԭz�A��̬O��~�H A. ��~��s�o�{�l�ҩ��k��v�T��k�ʤj�C B. �f�H�ͥ\��FEV1 <= 1,000 ml �O��N�T�ҡC C. �~�F��T��AT1�MT2��ɭ��O��|2��C D. �p�ӭM��X�{�P��갩�W�۲O�ڵ��O�]��C E. �p�ӭM��ӭM��M�쪬�ӭM��֡C (B) 19. �U�C��C�ʪ��ʪͯe��ԭz�A��̥��T�H A. ��f�A�C��q��T�J�C B. �C�ʤ��ު��̤��D�� (resistance) ��ͮ�~�̰��C C. ��ʯߦ��C��70 mmHg�A��l�J��C D. �f�Aatropine ��Ĥ�� ipratropium bromide�t�C E. �ͥ\��ˬdTLC�W�[�A��RV�Ϧӭ��C�C (D) 20. �U�C��اܵ��ġA��A��15 mg/kg/day��q�H 1. Isoniazid 2. Ethambutol 3. Rifampin 4. Pyrazinamide 5. Streptomycin A. 1,2 B. 2,3 C. 3,4 D. 1,3 E. 2,5 (A) 21. �U�C��دe�f��ͥ\��ˬd��DLco�|�W�[�H 1. �ͪw��X�� 2. �L�ͤ��~��{��ʤ߰I�� 3. �Ͷ��ֺ�� 4. �ͱ�� 5. �ͮ�~ A. 1,2 B. 2,3 C. 3,4 D. 1,3,5 E. 2,3,4 (E) 22. �U�C�U�دe�f�Ҥް_��ê��A��@�դ��ê�ۦP�H 1. ��F�� (brain stem infarction) 2. �~�{ 3. �B�ʯ��g��e�f (motor neuron disease) 4. �}��f�ް_��Ħ�g (acidosis) 5. ��g�ٵL�O (myasthenia gravis) A. 1,2,3 B. 1,2,4 C. 2,4,5 D. 3,4,5 E. 1,3,5